HomeProductsBioactive CompoundsAnti-Infective AgentsHSVNetivudine
Chemical structure of CAS 84558-93-0

Netivudine

In Stock•Starting at $135 for 1 mg
CAS No.84558-93-0
MDL No.N/A
MFC12H14N2O6
MW282.25
InChI KeyQLOCVMVCRJOTTM-SDNRWEOFSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$135In Stock
5 mgTo Be Confirmed$339In Stock
10 mgTo Be Confirmed$484In Stock
25 mgTo Be Confirmed$730In Stock
50 mgTo Be Confirmed$979In Stock
100 mgTo Be Confirmed$1331In Stock
200 mgTo Be Confirmed$1761In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.84558-93-0
Product NameNetivudine
Heavy Atom Count20Rotatable Bond Count2
Atom Stereo Count4Bond Stereo Count0
HBA7HBD4
TPSA124.780 ŲCharge0
Exact Mass282.08519Complexity667.00
pKa7.130XLogP-2.480

Related Articles

Studies related to this compound and its mechanism of action

Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents.

Antiviral chemistry & chemotherapy • Vol. 9, Issue 3 • 1998
PMID: 9875402DOI: 10.1177/095632029800900304

Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

Antiviral research • Vol. 35, Issue 3 • 1997
PMID: 9298756DOI: 10.1016/s0166-3542(97)00026-0

Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.

The Journal of antimicrobial chemotherapy • Vol. 37, Issue 3 • 1996
PMID: 9182115DOI: 10.1093/jac/37.3.583

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology • Vol. 14, Issue 4 • 1995
PMID: 7649195DOI: 10.1007/BF02116525

Documentation

Similar Products